Cytological smear is widely employed to analyse specimens obtained from endosonography-
guided fine-needle aspiration (EUS-FNA), but false-negative or inconclusive results may …

AIM: To clarify the effectiveness and safety of endoscopic ultrasound-guided fine-needle
aspiration (EUS-FNA) for the diagnosis of pancreatic cancer (PC). METHODS: Patients who …

Background The potential prognostic value of human equilibrative nucleoside transporter1
in pancreatic cancer receiving gemcitabine-based chemotherapy is variably reported …

Dr. William M. Steinberg Traditionally, the approach to the patient presenting with a
resectable mass in the pancreas has been to take the patient to surgery without a …

Background. There is a high incidence of inconclusive cytopathology at initial EUS‐FNA
(endoscopic ultrasound‐guided fine‐needle aspiration) for suspected malignant pancreatic …

Pancreatic ductal carcinoma, one of the leading causes of cancer mortality, is typically
diagnosed at an advanced stage, which significantly contributes to its high mortality rates …

Since its advent more than 20 years ago, endoscopic ultrasound (EUS) has undergone
evolution from an experimental to a diagnostic instrument and is now established as a …

Results: Pathogenic mutations in K-RAS, TP53, and PIK3CA differed significantly between
the three groups (P< 0.001, P= 0.018, and P= 0.026, respectively). Pathogenic mutations in …

Pancreatic cancer (PC) is a highly lethal malignancy, with a 5-year survival rate of 6%.
Cancer gene panel testing is expected to allow selection of suitable therapeutic drugs in …

Background Pancreatic cancer is an aggressive disease with a poor prognosis. Hereditary
factors have been reported in up to 10% of cases of pancreatic cancer. The clinical …